Cargando…
mRNA lipid nanoparticles induce immune tolerance to treat human diseases
Rapid developments in the coronavirus disease 2019 (COVID-19) mRNA vaccine showcased the power of lipid nanoparticle (LNP) delivery systems in fighting infectious diseases. In addition, mRNA therapeutics are also in development for cancer immunotherapy. Recently, mRNA therapy has been expanded to in...
Autores principales: | Cao, Wei, Xia, Tian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471105/ https://www.ncbi.nlm.nih.gov/pubmed/37724087 http://dx.doi.org/10.1515/mr-2023-0008 |
Ejemplares similares
-
Recent Advances in Site-Specific Lipid Nanoparticles
for mRNA Delivery
por: Xu, Xiao, et al.
Publicado: (2023) -
Lipid nanoparticles for mRNA delivery
por: Hou, Xucheng, et al.
Publicado: (2021) -
mRNA vaccine development for cholangiocarcinoma: a precise pipeline
por: Tang, Tian-Yu, et al.
Publicado: (2022) -
From lipids to lipid nanoparticles to mRNA vaccines
por: Horejs, Christine
Publicado: (2021) -
Commentary of the mRNA vaccines COVID-19
por: Vitiello, Antonio, et al.
Publicado: (2021)